The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, ...

U.S. telehealth upstart Hims & Hers Health, Inc. is planning to enter the Canadian market with an eye to selling generic ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

New study published by Truveta and Harvard Medical School A groundbreaking study published today in Pediatrics Open Science ...

Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, ...

Semaglutide, a popular anti-obesity drug, may come with a hidden cost: significant muscle loss, especially in women and older adults. A small study found that up to 40% of weight loss from semaglutide ...

Use of GLP-1 drugs for weight loss rose sharply in kids and adolescents after the American Academy of Pediatrics in 2023 recommended offering medications along with lifestyle adjustments such as ...